"Up the Price by How Much?"

Poll

Turing Pharmaceutical's CEO has backed down on the 4000% price hike for Daraprim, but is the damage done? Take our poll.

You’ve read about Turing Pharmaceuticals’ recent attempt to increase the cost of Daraprim by about 4000%.  

Do you think this move is:

A. Legitimate: funds will help subsidize new drug development
B. Motivated purely by financial gain and a harbinger of more to come
C. Not new: others have done it
D. A swan song: public and political pressure will stop this from becoming a trend
E. A priority issue for 2016 presidential candidates
F. Other

Newsletter

Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.

Recent Videos
© 2025 MJH Life Sciences

All rights reserved.